Avaxia Biologics, Inc., a clinical-stage biopharmaceutical company developing gut-targeted therapeutics, announced today that Kevin Sarney, CPA, has joined the company as Vice President, Finance and Administration.
Mr. Sarney is an accomplished finance and accounting professional with over 15 years of experience in the biotechnology industry in both early-stage and publicly traded companies. Prior to joining Avaxia, he worked as a consultant from 2009 to 2013 at various biotechnology and medical device companies in interim VP of Finance and Controller roles.
Help employers find you! Check out all the jobs and post your resume.
